Cite
MLA Citation
T. Takeuchi et al.. “FRI0200 Achievement of low disease activity (LDA) at 3 months predicts clinical remission (REM) at 1 year of infliximab (IFX) therapy in ra: post-hoc analysis of a randomized double-blind clinical study (rising study).” Annals of the rheumatic diseases, vol. 72, 2013, pp. A439–A440. http://access.bl.uk/ark:/81055/vdc_100137792617.0x000052